Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 4, 2009
View Archived Issues
CNTO-328-docetaxel combination active in metastatic castration-resistant prostate cancer
Read More
Disulfiram, a DNMT1 inhibitor with activity relevant to prostate cancer
Read More
Millennium initiates two phase II trials for Aurora A kinase inhibitor MLN-8237
Read More
Novexel's NXL-104/ceftazidime combination advances to phase II trials
Read More
Piramal completes acquisition of Minrad
Read More
Moberg Derma signs license and copromotion agreement for nail fungus drug K-101
Read More
Depomed completes enrollment in phase III clinical trial of DM-5689
Read More
Lab21 purchases majority shareholding in Biotec
Read More
Intellect Neurosciences' AD candidate Oxigon reported to have copper-binding properties
Read More
Chelsea announces results of phase II droxidopa study
Read More
Recent KuDOS and Cancer Research Technology patent describes novel DNA-PK inhibitors
Read More
New Met kinase inhibitors for cancer reported by Merck KGaA
Read More
Cediranib shows potential in docetaxel-resistant prostate cancer
Read More
RegeneRx completes enrollment and dosing in phase Ib clinical trial of RGN-352 in AMI
Read More
IDMC recommends continuation of clinical trial of Hana's Marqibo in ALL
Read More
Taisho scientists present new antidepressive NMU2 ligands
Read More
New peptides claimed by Les Biotechnologies Oceanova for dermatological disorders
Read More
Novel rivaroxaban prodrugs synthesized by Bayer researchers
Read More
FDA provides complete response to Erbitux head and neck cancer sBLA
Read More
Zonisamide reduces tremor scores in patients with essential tremor
Read More
Immatics completes recruitment in phase II IMA-901 trial in renal cell cancer
Read More
Anticonvulsants improve urodynamic parameters in rats with NDO
Read More
Astellas terminates ASP-2314/ACR-16 license agreement with Neurosearch
Read More
Zeria presents results from phase II Z-338 study in functional dyspepsia
Read More
Multiple Myeloma Research Foundation gives grants for two novel drug candidates
Read More
KV Pharmaceutical restructures company to focus on promotion of Acrux's Evamist
Read More
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe